title: Another beneficial effect of rituximab on refractory ANCA-associated vasculitis: the role of interleukin-17 suppression?
authors.forename: S J
authors.initials: SJ
authors.lastname: Park
authors.forename: J I
authors.initials: JI
authors.lastname: Shin
mesh_terms: D000818:Animals; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D020381:Interleukin-17 / Q000276:immunology* / Q000378:metabolism; D051379:Mice; D000069283:Rituximab; D058504:Th17 Cells / Q000187:drug effects / Q000276:immunology / Q000378:metabolism
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D020381:Interleukin-17; D000069283:Rituximab